Skip to main content

Animations

MJFF Publications

7421 - 7430 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2015
  • 2021
  • 2024
  • 2023
  • 2020
  • 2018
  • 2025
  • 2024
  • 2022
  • Summary Details
    OPEN
    Title: Comprehensive real time remote monitoring for Parkinson’s disease using Quantitative DigitoGraphy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00751-w
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Fall risk is associated with amplified functional connectivity of the central executive network in patients with Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-015-7865-6
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platforms
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12079
    Citation Count: 149
  • Summary Details
    OPEN
    Title: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49256-3
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-223433
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28382
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27404
    Citation Count: 15
  • Summary Details
    OPEN
    Title: A study of RNA splicing and protein expression in the living human brain
    Journal Name: PLOS One
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0332651
    Citation Count: 0
  • Summary Details
    OPEN
    Title: POLCAM: instant molecular orientation microscopy for the life sciences
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-024-02382-8
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29042
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.